Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-06-15

FDA Approved: ONFI — Supplemental Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for ONFI (clobazam) submitted by Lundbeck Pharmaceuticals LLC. The approval updates the drug's labeling as part of t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ONFI (clobazam)

Snippet

SUPPL AP for ONFI (CLOBAZAM)